Here are some key papers and press releases relating to standards and direction being taken by leading hospitals and institutions. If there is something else that you’re looking for, please call us as we probably have it:<\/p>\n
HealthPRO Awards IOS 5-Year Contract for\u00a0<\/span><\/strong>CompoundingQMS\u2122\u00a0<\/strong><\/span>and Third Party NAPRA Certified Training<\/span><\/strong><\/a><\/p>\n Just 2 CSTD Products Pass NIOSH’s 2015 Vapor Containment Performance Protocol<\/a><\/strong><\/span><\/p>\n Application of vapor containment protocol for closed system transfer devices to assess efficacy during pharmacy compounding and administration of hazardous drugs<\/span><\/b><\/a><\/span><\/p>\n CompoundingQMS Press Release<\/a>\u00a0<\/strong><\/span><\/p>\n 2018 NIOSH Proposed Hazardous Drug List: Out for Comment<\/a><\/strong><\/p>\n Financial and Safety Benefits of Closed System Transfer Devices, <\/a>Cathy Bratt-Rico<\/a><\/strong><\/p>\n A Review of the Oncology Under-Dosing Incident, Jake J. Thiessen, Ph.D. report to MHLTC<\/a><\/strong><\/p>\n Assessment of Closed System Transfer Devices 5-FU,\u00a0<\/a>A Comparative Report<\/a><\/strong><\/p>\n NAPRA Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations<\/a><\/strong><\/p>\n NAPRA Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations<\/a> <\/strong><\/p>\n EQUASHIELDII\u00ae and Innovative OncoSolutions Press\u00a0<\/a>Release<\/a><\/strong><\/p>\n